181 related articles for article (PubMed ID: 28163765)
1. Pupillary Involvement in Miller Fisher Syndrome.
Kaymakamzade B; Selcuk F; Koysuren A; Colpak AI; Mut SE; Kansu T
Neuroophthalmology; 2013; 37(3):111-115. PubMed ID: 28163765
[TBL] [Abstract][Full Text] [Related]
2. Atypical Miller Fisher Syndrome with Anisocoria and Rapidly Fluctuating Pupillary Diameter.
Gupta G; Liu A
Case Rep Neurol Med; 2015; 2015():472843. PubMed ID: 26380131
[TBL] [Abstract][Full Text] [Related]
3. Bilateral internal ophthalmoplegia as an initial sole manifestation of Miller Fisher syndrome.
Bae JS; Kim JK; Kim SH; Kim OK
J Clin Neurosci; 2009 Jul; 16(7):963-4. PubMed ID: 19339185
[TBL] [Abstract][Full Text] [Related]
4. Acute bilateral mydriasis associated with anti-GQ1b antibody.
Fleury V; Aqallal A; Lagrange E; Besson G; Caudie C
J Clin Neurosci; 2010 Apr; 17(4):514-5. PubMed ID: 20093031
[TBL] [Abstract][Full Text] [Related]
5. Acute ophthalmoplegia with pupillary areflexia associated with anti-GQ1b antibody.
Chan YC; Wilder-Smith E; Chee MW
J Clin Neurosci; 2004 Aug; 11(6):658-60. PubMed ID: 15261245
[TBL] [Abstract][Full Text] [Related]
6. Anti-GQ1b-Negative Miller Fisher Syndrome with Acute Areflexic Mydriasis and Cholinergic Supersensitivity.
Yıldız ÖK; Balaban H; Özdemir S; Bolayır E; Topaktas S
Neuroophthalmology; 2011; 35(1):40-42. PubMed ID: 27956933
[TBL] [Abstract][Full Text] [Related]
7. Anti-GQ1b antibody syndrome presenting as acute isolated bilateral ophthalmoplegia: Report on two patients and review of the literature.
Guisset F; Ferreiro C; Voets S; Sellier J; Debaugnies F; Corazza F; Deconinck N; Prigogine C
Eur J Paediatr Neurol; 2016 May; 20(3):439-43. PubMed ID: 26924168
[TBL] [Abstract][Full Text] [Related]
8. Acute ophthalmoparesis and persistent mydriasis: expanding the clinical spectrum of anti-GQ1b positive cranial neuropathy in a 5.5-year-old girl.
Güneş AS; Genç HM; Yalçın EU; Yılmaz V; Direskeneli GS; Kara B
Turk J Pediatr; 2019; 61(5):794-797. PubMed ID: 32105016
[TBL] [Abstract][Full Text] [Related]
9. Role of anti-GQ1B antibody in differential diagnosis of acute ophthalmoparesis.
Boylu EE; Toğrol RE; Senol MG; Ozdağ MF; Saraçoğlu M
Neuropsychiatr Dis Treat; 2010 May; 6():119-22. PubMed ID: 20505843
[TBL] [Abstract][Full Text] [Related]
10. [Alert patients with mydriasis and fixed pupils].
Meys VE; Koehler PJ
Ned Tijdschr Geneeskd; 2014; 157():A6581. PubMed ID: 24690486
[TBL] [Abstract][Full Text] [Related]
11. Miller Fisher syndrome: toward a more comprehensive understanding.
Li H; Yuan J
Chin Med J (Engl); 2001 Mar; 114(3):235-9. PubMed ID: 11780304
[TBL] [Abstract][Full Text] [Related]
12. [Miller-Fisher syndrome associated with monoclonal IgG lambda antibodies against ganglioside GQ1b].
Caudie C; Lagrange E
Ann Biol Clin (Paris); 2010; 68(3):351-4. PubMed ID: 20478781
[TBL] [Abstract][Full Text] [Related]
13. Atypical clinical manifestations of Miller Fisher syndrome.
Jung JH; Oh EH; Shin JH; Kim DS; Choi SY; Choi KD; Choi JH
Neurol Sci; 2019 Jan; 40(1):67-73. PubMed ID: 30232672
[TBL] [Abstract][Full Text] [Related]
14. Acute bilateral ophthalmoparesis with pupilary areflexical mydriasis in miller-fisher syndrome treated with intravenous immunoglobulin.
Papanikolaou T; Gray C; Boothman B; Naylor G; Mariatos G
J Ophthalmol; 2010; 2010():. PubMed ID: 20871658
[TBL] [Abstract][Full Text] [Related]
15. Acute eye movement-retained internal ophthalmoplegia in atypical Miller Fisher syndrome variants are associated with IgG anti-GQ1b antibodies.
Murakami K; Miyamoto K; Terayama A; Yoshikawa K; Kuwahara M; Ito H
J Neuroimmunol; 2022 Jul; 368():577880. PubMed ID: 35537332
[TBL] [Abstract][Full Text] [Related]
16. [Ataxia with ophthalmoplegia: Miller-Fisher syndrome with anti-GQ1b antibody positivity].
Guilloton L; Camarasa C; Agard E; Tondeur G; Dot C; Drouet A
J Fr Ophtalmol; 2014 Feb; 37(2):89-92. PubMed ID: 24513384
[TBL] [Abstract][Full Text] [Related]
17. Atypical Miller Fisher syndrome with GQ1b antibodies.
Paine MA; Keir G; Plant GT
J Clin Neurosci; 1996 Jul; 3(3):268-71. PubMed ID: 18638884
[TBL] [Abstract][Full Text] [Related]
18. Miller Fisher syndrome: an updated narrative review.
Noioso CM; Bevilacqua L; Acerra GM; Della Valle P; Serio M; Vinciguerra C; Piscosquito G; Toriello A; Barone P; Iovino A
Front Neurol; 2023; 14():1250774. PubMed ID: 37693761
[TBL] [Abstract][Full Text] [Related]
19. Progressive subacute Miller-Fisher syndrome successfully treated with plasmapheresis.
Ejma M; Waliszewska-Prosół M; Hofman A; Budrewicz S; Podemski R; Bilińska M; Koszewicz M
Neurol Neurochir Pol; 2015; 49(2):137-8. PubMed ID: 25890931
[TBL] [Abstract][Full Text] [Related]
20. Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain-Barre syndromes.
Kanzaki M; Kaida K; Ueda M; Morita D; Hirakawa M; Motoyoshi K; Kamakura K; Kusunoki S
J Neurol Neurosurg Psychiatry; 2008 Oct; 79(10):1148-52. PubMed ID: 18339728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
